Beckie Robertson specializes in early-stage investing in medical devices and diagnostics at Versant. Ms. Robertson’s career encompasses 23 years of venture capital and operating experience in medical products as an engineer, entrepreneur, corporate executive, and investor. Before co-founding Versant, Ms. Robertson was a general partner at Institutional Venture Partners (IVP). From 1994-1996, Ms. Robertson served as Sr. VP at Chiron Diagnostics, a division of Chiron Corporation, where she had responsibility for the $200 million Critical Care business unit. In addition, Ms. Robertson was VP of business development where she led numerous deals in support of Chiron Diagnostics business and technology objectives. Prior to that, she was a co-founder and VP at Egis, an IVP portfolio company, and held senior management positions in operations and finance at Lifescan, a Johnson & Johnson Company. During her seven-year term at Lifescan, the company grew from an early-stage venture-funded company to a worldwide market leader in diabetes diagnostics. Ms. Robertson has served as a director of ProDuct Health (sold), Appriva Medical (sold), Quantum Dot (sold), Coalescent (sold) and Liposonix (sold), and currently serves as a director for Benvenue, ConcepTx Medical, Intuity Medical, Myocor, NeoGuide, Novasys, Osteolign and Spiration. In addition, Ms. Robertson serves as an advisor to Orametrix, and The Innovation Factory, a medical devices incubator, and is now serving on the Investment Committee for the Cleveland Clinic Foundation (CCF).